Itzhak Avital, MD, FACS

Itzhak Avital, MD, FACS

Peritoneal Surface Malignancy Center

Executive Director of the Bon Secours Cancer Institute
5855 Bremo Road
Suite 506
Richmond, VA 23226
Phone: 804-893-8676
Fax: 804-285-0360
Maps and Directions

Bon Secours Cancer Institute Surgical Oncology

5855 Bremo Road
MOB North, Suite 606
Richmond, VA 23226
Phone: 804-893-8681
Fax: 804-287-8525
Maps and Directions

Hospital Affiliations

St. Mary's

Specialties

Oncology

Oncologic Surgery

Peritoneal Surface Malignancies

Surgery

Hepatopancreatobiliary Surgery

Colorectal Surgery

Endocrine Surgery

Education and Training

Medical Degree

New York University School of Medicine

General Surgery Residency

Cedars-Sinai Medical Center, UCLA School of Medicine

Surgical Oncology Fellowship

Memorial Sloan-Kettering Cancer Center (MSKCC)

Hepatobiliary Fellowship

Memorial Sloan-Kettering Cancer Center (MSKCC)

Bio

Dr. Avital is the Executive Medical Director of the Bon Secours Cancer Institute. He attended Touro College and New York University for his undergraduate degree in biology and chemistry, and received his medical degree from New York University School of Medicine, where he participated in the honors program. In addition, he is currently completing his MBA at George Washington University in Washington, D.C. He completed his medical training and surgical residency at Cedars-Sinai Medical Center, UCLA School of Medicine in Los Angeles before continuing on to complete three postgraduate fellowships and a two-year fellowship in surgical research in the bioartificial liver support laboratory under the tutelage of Dr. Achilles Demetriou. Additionally, Dr. Avital completed a surgical oncology fellowship and a hepatobiliary fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. Subsequently, Dr. Avital joined the Surgery Branch of the National Cancer Institute (NCI)/National Institutes of Health (NIH), Bethesda, Maryland, where he built and later appointed the Head of GI and HPB malignancies section of the NCI.

As a result of his research, Dr. Avital has published over 80 peer-reviewed articles, many book chapters and discovered a new class of bone marrow-derived adult liver stem cells, subsequently patenting several methods for isolation of stem cells. He also discovered a new form of familial gastric cancer and performed the first full DNA sequencing for familial cancer in the NCI. Additionally, he serves on several editorial boards including the Journal of Cancer, Journal of Surgical Oncology, and many others. He holds two professorships - Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Professor of Surgery at University of Novi Sad, Serbia. Dr. Avital was a cofounder of the National Institutes of Health Cancer Stem Cell Consortium and Bon Secours Cancer Institute.

As an expert in the management of complex, advanced cancers, Dr. Avital is listed among the top surgeons in the country in the Guide to America’s Top Surgeons, 2012. His expertise as a clinician, trialist and basic scientist coupled with his superior proficiency in the management of malignancies of the liver, pancreas, stomach, rectum, retroperitoneal sarcoma, adrenal glands, GIST and other gastrointestinal tract tumors adds significantly to Bon Secours’ ability to bring the best care and outcomes available to those affected by cancer.

Return to Search Results >>

good sharing

twitter feed

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System